Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization. / Lange, K H; Hougen, H P; Høiby, N; Fomsgaard, Anette; Rygaard, J; Johansen, H K.

In: A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica, Vol. 103, No. 5, 1995, p. 367-74.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Lange, KH, Hougen, HP, Høiby, N, Fomsgaard, A, Rygaard, J & Johansen, HK 1995, 'Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization', A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 103, no. 5, pp. 367-74.

APA

Lange, K. H., Hougen, H. P., Høiby, N., Fomsgaard, A., Rygaard, J., & Johansen, H. K. (1995). Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization. A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 103(5), 367-74.

Vancouver

Lange KH, Hougen HP, Høiby N, Fomsgaard A, Rygaard J, Johansen HK. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization. A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 1995;103(5):367-74.

Author

Lange, K H ; Hougen, H P ; Høiby, N ; Fomsgaard, Anette ; Rygaard, J ; Johansen, H K. / Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization. In: A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 1995 ; Vol. 103, No. 5. pp. 367-74.

Bibtex

@article{b4f13c2889dd4aec8903da1624cc9d53,
title = "Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization",
abstract = "In a rat model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis, we investigated the possibility of preventing chronic lung inflammation or decreasing the progression of the infection. We compared the lethality, pathology, bacterial clearance, and immunogenicity after stimulation of the non-specific defence mechanisms by Escherichia coli lipopolysaccharide (LPS) or P. aeruginosa sonicate, or the acquired specific immune response by vaccination with the same bacterial antigens. One day prior to challenge with P. aeruginosa embedded in alginate beads, rats were stimulated with either E. coli LPS or P. aeruginosa sonicate. Four and two weeks prior to challenge other rats were vaccinated with either E. coli LPS or P. aeruginosa sonicate. Controls did not receive any stimulation or vaccination. The lethality after challenge was lower in rats stimulated with E. coli LPS (p = 0.02) or vaccinated with P. aeruginosa sonicate (p = 0.03) as compared to controls. The histopathology of the surviving rats showed an acute inflammation dominated by polymorphonuclear leukocytes (PMNs), but the offending bacteria were not completely eliminated in any group. The increased survival was probably due to earlier recruitment of PMNs most likely mediated by either cytokines and other chemotactic factors (stimulated group) or the immune response in concert with the complement cascade (vaccinated group). The results of the present and previous vaccination studies show that it is possible to improve survival but not to prevent the chronic P. aeruginosa lung infection and inflammation caused by alginate-embedded bacteria.",
keywords = "Animals, Antibodies, Bacterial, Bacterial Vaccines, Chronic Disease, Escherichia coli, Female, Immunotherapy, Lipopolysaccharides, Pseudomonas Infections, Pseudomonas aeruginosa, Rats, Rats, Inbred Lew, Vaccination",
author = "Lange, {K H} and Hougen, {H P} and N H{\o}iby and Anette Fomsgaard and J Rygaard and Johansen, {H K}",
year = "1995",
language = "English",
volume = "103",
pages = "367--74",
journal = "A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica",
issn = "0903-4641",
publisher = "Wiley Online",
number = "5",

}

RIS

TY - JOUR

T1 - Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization

AU - Lange, K H

AU - Hougen, H P

AU - Høiby, N

AU - Fomsgaard, Anette

AU - Rygaard, J

AU - Johansen, H K

PY - 1995

Y1 - 1995

N2 - In a rat model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis, we investigated the possibility of preventing chronic lung inflammation or decreasing the progression of the infection. We compared the lethality, pathology, bacterial clearance, and immunogenicity after stimulation of the non-specific defence mechanisms by Escherichia coli lipopolysaccharide (LPS) or P. aeruginosa sonicate, or the acquired specific immune response by vaccination with the same bacterial antigens. One day prior to challenge with P. aeruginosa embedded in alginate beads, rats were stimulated with either E. coli LPS or P. aeruginosa sonicate. Four and two weeks prior to challenge other rats were vaccinated with either E. coli LPS or P. aeruginosa sonicate. Controls did not receive any stimulation or vaccination. The lethality after challenge was lower in rats stimulated with E. coli LPS (p = 0.02) or vaccinated with P. aeruginosa sonicate (p = 0.03) as compared to controls. The histopathology of the surviving rats showed an acute inflammation dominated by polymorphonuclear leukocytes (PMNs), but the offending bacteria were not completely eliminated in any group. The increased survival was probably due to earlier recruitment of PMNs most likely mediated by either cytokines and other chemotactic factors (stimulated group) or the immune response in concert with the complement cascade (vaccinated group). The results of the present and previous vaccination studies show that it is possible to improve survival but not to prevent the chronic P. aeruginosa lung infection and inflammation caused by alginate-embedded bacteria.

AB - In a rat model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis, we investigated the possibility of preventing chronic lung inflammation or decreasing the progression of the infection. We compared the lethality, pathology, bacterial clearance, and immunogenicity after stimulation of the non-specific defence mechanisms by Escherichia coli lipopolysaccharide (LPS) or P. aeruginosa sonicate, or the acquired specific immune response by vaccination with the same bacterial antigens. One day prior to challenge with P. aeruginosa embedded in alginate beads, rats were stimulated with either E. coli LPS or P. aeruginosa sonicate. Four and two weeks prior to challenge other rats were vaccinated with either E. coli LPS or P. aeruginosa sonicate. Controls did not receive any stimulation or vaccination. The lethality after challenge was lower in rats stimulated with E. coli LPS (p = 0.02) or vaccinated with P. aeruginosa sonicate (p = 0.03) as compared to controls. The histopathology of the surviving rats showed an acute inflammation dominated by polymorphonuclear leukocytes (PMNs), but the offending bacteria were not completely eliminated in any group. The increased survival was probably due to earlier recruitment of PMNs most likely mediated by either cytokines and other chemotactic factors (stimulated group) or the immune response in concert with the complement cascade (vaccinated group). The results of the present and previous vaccination studies show that it is possible to improve survival but not to prevent the chronic P. aeruginosa lung infection and inflammation caused by alginate-embedded bacteria.

KW - Animals

KW - Antibodies, Bacterial

KW - Bacterial Vaccines

KW - Chronic Disease

KW - Escherichia coli

KW - Female

KW - Immunotherapy

KW - Lipopolysaccharides

KW - Pseudomonas Infections

KW - Pseudomonas aeruginosa

KW - Rats

KW - Rats, Inbred Lew

KW - Vaccination

M3 - Journal article

C2 - 7654361

VL - 103

SP - 367

EP - 374

JO - A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica

JF - A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica

SN - 0903-4641

IS - 5

ER -

ID: 44354838